Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 11
1946 47
1947 56
1948 74
1949 49
1950 3
1951 258
1952 440
1953 416
1954 360
1955 323
1956 289
1957 266
1958 248
1959 165
1960 129
1961 211
1962 150
1963 7
1964 18
1965 257
1966 562
1967 693
1968 770
1969 974
1970 962
1971 1064
1972 983
1973 1133
1974 1136
1975 1057
1976 1056
1977 1042
1978 1141
1979 1242
1980 1162
1981 1276
1982 1372
1983 1615
1984 1817
1985 1842
1986 1840
1987 1886
1988 2096
1989 2108
1990 2205
1991 2261
1992 2439
1993 2604
1994 2655
1995 2483
1996 2653
1997 2853
1998 2919
1999 3107
2000 3138
2001 3400
2002 3901
2003 4189
2004 4332
2005 4934
2006 4937
2007 5175
2008 5666
2009 5981
2010 6325
2011 6862
2012 7241
2013 7351
2014 7672
2015 7669
2016 7616
2017 7492
2018 7295
2019 3559
2020 41
Text availability
Article attribute
Article type
Publication date

Search Results

163,222 results
Results by year
Filters applied: . Clear all
Page 1
New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.
Behin A and Le Panse R. J Neuromuscul Dis 2018 - Review. PMID 30010142 Free PMC article.
It is a prototype organ-specific autoimmune disease with well-defined antigenic targets mainly the nicotinic acetylcholine receptor (AChR). ...In this review, based on recent experimental data on MG or based on results from clinical trials for other autoimmune diseases, we explore new potential therapeutic approaches for MG patients, going from non-specific approaches with the use of stem cells with their anti-inflammatory and immunosuppressive properties to targeted therapies using monoclonal antibodies specific for cell-surface antigens or circulating molecules....
It is a prototype organ-specific autoimmune disease with well-defined antigenic targets mainly the nicotinic acetylcholine receptor ( …
Transplantation and Alternatives to Treat Autoimmune Diseases.
Shende P, et al. Adv Exp Med Biol 2018 - Review. PMID 29516308
Transplantation is considered as one of the methods for the treatment of autoimmune diseases. There are different sorts of transplantation which improved the situation for the cure of different kinds of autoimmune diseases. ...Using 3D printing and artificial intelligence are some of the recent trends that may be used for the management of autoimmune diseases....
Transplantation is considered as one of the methods for the treatment of autoimmune diseases. There are different sorts of tra …
Extracorporeal photopheresis for the treatment of autoimmune diseases.
Adamski J, et al. Transfus Apher Sci 2015 - Review. PMID 25886694
Current therapies aimed at treating autoimmune disorders result in generalized immunosuppression and place the patient at increased risk for infection and malignancy. ...Several clinical trials suggest that ECP may be used to treat a broad spectrum of autoimmune diseases....
Current therapies aimed at treating autoimmune disorders result in generalized immunosuppression and place the patient at increased r …
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Lünemann JD, et al. Neurotherapeutics 2016 - Review. PMID 26400261 Free PMC article.
Owing to its anti-inflammatory efficacy in various autoimmune disease conditions, intravenous immunoglobulin (IVIG)-pooled IgG obtained from the plasma of several thousands individuals-has been used for nearly three decades and is proving to be efficient in a growing number of neurological diseases. ...This review covers new developments in the immunobiology and clinical applications of IVIG in neurological diseases....
Owing to its anti-inflammatory efficacy in various autoimmune disease conditions, intravenous immunoglobulin (IVIG)-pooled IgG obtain …
Immunosuppressive/Autoimmune Disorders.
Richard-Eaglin A and Smallheer BA. Nurs Clin North Am 2018 - Review. PMID 30099999
Autoimmune disorders are a category of diseases in which the immune system attacks healthy cells as a result of a dysfunction of the acquired immune system. ...
Autoimmune disorders are a category of diseases in which the immune system attacks healthy cells as a result of a dysfunction
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.
Cipriani P, et al. Autoimmun Rev 2013 - Review. PMID 23183379
Moreover, several works suggest that MSCs are defective in autoimmune diseases. These aspects are now considered the most intriguing aspect of their biology, introducing the possibility that these cells might be used as effective therapy in autoimmune diseases. ...As autoimmune diseases can be transferred, or alternatively, cured, by stem cell transplantation, a defect in the hemopoietic stem cell as a cause of autoimmune diseases may be postulated. ...
Moreover, several works suggest that MSCs are defective in autoimmune diseases. These aspects are now considered the most intr …
The management of hypophysitis
Karaca Z and Kelestimur F. Minerva Endocrinol 2016. PMID 26963662 Free article.
Hypophysitis is generally accepted as an autoimmune disease which is characterized by inflammation and cellular infiltration of the pituitary gland. ...
Hypophysitis is generally accepted as an autoimmune disease which is characterized by inflammation and cellular infiltration of the p …
"How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis.
Roccatello D. Autoimmun Rev 2017. PMID 28780080 Free article.
As such, these presentations represent the state of the art on the pathophysiology of autoimmune diseases as well as the most recent insights into the management of these pathologic conditions. ...This Satellite Congress was mainly addressed to the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitis: advances on induction therapy and maintenance treatment. ...
As such, these presentations represent the state of the art on the pathophysiology of autoimmune diseases as well as the most …
Gene therapy for autoimmune diseases: quo vadis?
Chernajovsky Y, et al. Nat Rev Immunol 2004 - Review. PMID 15459671
Biological therapies using antibodies and cytokines are becoming widespread for the treatment of chronic inflammatory autoimmune diseases. ...This review summarizes the ingenuity, sophistication and variety of gene-therapy approaches that have been taken in the design of therapeutic molecules and vectors, the engineering of cells and the regulation of gene expression for the targeting of disease outcome. ...
Biological therapies using antibodies and cytokines are becoming widespread for the treatment of chronic inflammatory autoimmune d
163,222 results
Jump to page
Feedback